Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-285963
Filing Date
2022-11-16
Accepted
2022-11-15 19:56:02
Documents
13
Period of Report
2022-11-10
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d408792d8ka.htm   iXBRL 8-K/A 27713
2 EX-99.1 d408792dex991.htm EX-99.1 105235
  Complete submission text file 0001193125-22-285963.txt   276727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imra-20221110.xsd EX-101.SCH 2497
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20221110_lab.xml EX-101.LAB 20180
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20221110_pre.xml EX-101.PRE 12558
7 EXTRACTED XBRL INSTANCE DOCUMENT d408792d8ka_htm.xml XML 5169
Mailing Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446
Business Address 1309 BEACON STREET SUITE 300 BROOKLINE MA 02446 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39247 | Film No.: 221392667
SIC: 2834 Pharmaceutical Preparations